Efficacy and Safety of SR1375 in Adult Patients With CAP
Clinical trial NCT06577558 · RECRUITING
Trial details
- NCT number
- NCT06577558
- Sponsor
- Shanghai SIMR Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-10
- Primary completion
- 2025-10-15
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.